It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
AMRX’s FA Score shows that 1 FA rating(s) are green whileCRK’s FA Score has 1 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
AMRX’s TA Score shows that 5 TA indicator(s) are bullish while CRK’s TA Score has 4 bullish TA indicator(s).
AMRX (@Pharmaceuticals: Other) experienced а +1.63% price change this week, while CRK (@Oil & Gas Production) price change was -6.98% for the same time period.
The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +5.53%. For the same industry, the average monthly price growth was -0.55%, and the average quarterly price growth was -7.74%.
The average weekly price growth across all stocks in the @Oil & Gas Production industry was +2.15%. For the same industry, the average monthly price growth was -6.56%, and the average quarterly price growth was -6.92%.
AMRX is expected to report earnings on Aug 07, 2025.
CRK is expected to report earnings on Aug 05, 2025.
Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.
@Oil & Gas Production (+2.15% weekly)The oil and gas production segment includes companies that specialize in exploration, development, and production of oil and natural gas. These companies are focused on upstream operations. Companies typically identify deposits, drill wells, and extract raw materials from underground. The industry also includes related services like rig operations, feasibility studies, machinery rentals etc. Several operators in this industry work with various types of contractors such as engineering procurement and construction contractors, as well as with joint-venture partners and oil field service companies. Oil and gas often involves large fixed costs of production; so, declining crude oil prices, for example, is a potential negative for this industry. Conoco Phillips, EOG Resources, Inc. and Pioneer Natural Resources Company are some examples of companies operating in this space.
AMRX | CRK | AMRX / CRK | |
Capitalization | 1.87B | 2.72B | 69% |
EBITDA | 400M | 1.02B | 39% |
Gain YTD | -5.556 | 0.933 | -595% |
P/E Ratio | 90.00 | 12.26 | 734% |
Revenue | 2.39B | 1.57B | 153% |
Total Cash | 91.5M | 16.7M | 548% |
Total Debt | 2.75B | 2.71B | 101% |
AMRX | CRK | ||
---|---|---|---|
OUTLOOK RATING 1..100 | 28 | 82 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 50 Fair valued | 50 Fair valued | |
PROFIT vs RISK RATING 1..100 | 51 | 37 | |
SMR RATING 1..100 | 96 | 91 | |
PRICE GROWTH RATING 1..100 | 60 | 41 | |
P/E GROWTH RATING 1..100 | 22 | 1 | |
SEASONALITY SCORE 1..100 | n/a | n/a |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
AMRX's Valuation (50) in the Pharmaceuticals Major industry is in the same range as CRK (50) in the Oil And Gas Production industry. This means that AMRX’s stock grew similarly to CRK’s over the last 12 months.
CRK's Profit vs Risk Rating (37) in the Oil And Gas Production industry is in the same range as AMRX (51) in the Pharmaceuticals Major industry. This means that CRK’s stock grew similarly to AMRX’s over the last 12 months.
CRK's SMR Rating (91) in the Oil And Gas Production industry is in the same range as AMRX (96) in the Pharmaceuticals Major industry. This means that CRK’s stock grew similarly to AMRX’s over the last 12 months.
CRK's Price Growth Rating (41) in the Oil And Gas Production industry is in the same range as AMRX (60) in the Pharmaceuticals Major industry. This means that CRK’s stock grew similarly to AMRX’s over the last 12 months.
CRK's P/E Growth Rating (1) in the Oil And Gas Production industry is in the same range as AMRX (22) in the Pharmaceuticals Major industry. This means that CRK’s stock grew similarly to AMRX’s over the last 12 months.
AMRX | CRK | |
---|---|---|
RSI ODDS (%) | 3 days ago79% | 3 days ago76% |
Stochastic ODDS (%) | 3 days ago82% | 3 days ago71% |
Momentum ODDS (%) | 3 days ago83% | 3 days ago82% |
MACD ODDS (%) | 3 days ago88% | 3 days ago60% |
TrendWeek ODDS (%) | 3 days ago81% | 3 days ago77% |
TrendMonth ODDS (%) | 3 days ago74% | 3 days ago79% |
Advances ODDS (%) | 3 days ago81% | 11 days ago83% |
Declines ODDS (%) | 20 days ago77% | 6 days ago79% |
BollingerBands ODDS (%) | 3 days ago81% | 3 days ago90% |
Aroon ODDS (%) | 3 days ago74% | 3 days ago81% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
OBIOX | 20.07 | 0.09 | +0.45% |
Oberweis International Opps Inv | |||
VDADX | 51.20 | 0.10 | +0.20% |
Vanguard Dividend Appreciation Index Adm | |||
OANWX | 23.60 | 0.04 | +0.17% |
Oakmark Global Select Institutional | |||
FSIUX | 25.02 | -0.02 | -0.08% |
Invesco Dividend Income R5 | |||
BVEIX | 19.62 | -0.03 | -0.15% |
Becker Value Equity Institutional |
A.I.dvisor indicates that over the last year, AMRX has been loosely correlated with HROW. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if AMRX jumps, then HROW could also see price increases.
Ticker / NAME | Correlation To AMRX | 1D Price Change % | ||
---|---|---|---|---|
AMRX | 100% | +0.81% | ||
HROW - AMRX | 39% Loosely correlated | +1.91% | ||
VTRS - AMRX | 36% Loosely correlated | +1.25% | ||
TEVA - AMRX | 33% Poorly correlated | +1.02% | ||
PRGO - AMRX | 33% Poorly correlated | +1.33% | ||
ORGO - AMRX | 32% Poorly correlated | +0.66% | ||
More |
A.I.dvisor indicates that over the last year, CRK has been closely correlated with RRC. These tickers have moved in lockstep 82% of the time. This A.I.-generated data suggests there is a high statistical probability that if CRK jumps, then RRC could also see price increases.